pwrm ob News

Gen-Probe (Nasdaq:GPRO) announced recently that GPRO has submitted a Premarket Approval Application to the US Food and Drug Administration for its PROGENSA® PCA3 assay

Power3 Medical Products, Inc. announced recently that it has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc.

Companies On the Move Presented By PennytoBuck.com - Delivery Technology Solutions, Inc., DTSL.PK, Power3 Medical Products, PWRM.OB, UDR Inc, UDR, Ultra Petroleum Corp, UPL

Happy Sunday News From PennytoBuck.com - Sturm, Ruger & Company,RGR, Power3 Medical Products,PWRM.OB

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases,

PWRM delivered four poster presentations at the 2010 International Conference on Alzheimer’s Disease (ICAD) in Honolulu, Hawaii

Delivery Technology Solutions, Inc. (Pinksheets:DTSL), the leader in delivery management technology, has completed participation at one of the largest restaurant franchisee conventions, held July 22-25, 2010

Wall Street Report From PennytoBuck.com - Power3 Medical, PWRM.OB, MUSCLEPHARM, MSLP.OB, Walgreens, WAG, Walmart, WMT

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases

These Companies Are On Stock-PR's Watch List - Power3 Medical Products, PWRM.OB, Parker Drilling, PKD, Parker Hannifin Corporation, PH, Park-Ohio Holdings Corp, PKOH

Power3 has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China

Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.

This is a very exciting time for Power3 Medical Products (PWRM.OB). Power3 Medical has remained focused on breast cancer and neurodegenerative diseases

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases,

Power3 Medical Products, Inc., announced recently that it has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc.

Power3 has filed several patent applications for its NuroPro technology

PWRM delivered four poster presentations at the 2010 International Conference on Alzheimer’s Disease (ICAD) in Honolulu, Hawaii.

Power3 has filed several patent applications for its NuroPro® technology

Power3 has filed several patent applications for its NuroPro technology that are currently pending.

Power3 Medical Hits a Grand Slam at ICAD With Four Alzheimer’s Poster Presentations

Power3 Medical Announces Execution of Definitive Agreement to Acquire Rozetta-Cell Life Sciences

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease.

PWRM engages in the development and marketing

The Cheesecake Factory in Bridgewater, New Jersey

Stock Update On PWRM, TAXS, USB for August 31st, 2010 from PennyToBuck.com

Army Major Fred Hackett Resumes Role as General Counsel at TaxMasters, Inc.

PROT recently announced that Mr. Michael Cohen, Chairman and CEO, is scheduling a multi-city European road trip

Stock Highlight On GENZ, PWRM, ENZ from PennytoBuck.com

PennyToBuck Stock Updates on PWRM, HLF, STEM for August 26th, 2010

NuroPro now extends into the pharmaceutical arena due to its ability to predict and monitor the response to drug treatment

Power3 Medical Products, Inc. NuroPro was originally indicated for diagnostics to determine whether or not a patient had Alzheimer’s disease.

Qualcomm Incorporated and MTN South Africa announced their successful collaboration in providing fans attending the 2010 FIFA World Cup™ with a quality 3G user experience.

Bio-Rad’s New SsoFast™ EvaGreen® Control Assay Helps Labs Verify Real-Time PCR System Performance

PWRM has unexpectedly discovered new and unprecedented findings regarding clinically important differences in the response of the NuroPro

Power3 Medical Products, Inc. (OTCBB:PWRM.OB) strives to become the premier biotechnology company specializing in the commercialization of proteomics IP for the diagnosis and treatment of disease by using cutting edge technologies.

discovered new and unprecedented findings regarding clinically important differences in the response of the NuroPro

Power3 Medical Products (OTCBB: PWRM.OB) BC-SeraPro™ was developed and its performance characteristics determined by the Power3 Medical Products Laboratories.

Urologix, Inc. (Nasdaq:ULGX), announced Christopher R. Barys has joined the Board of Directors effective August 6, 2010.

PWRM BC-SeraPro was developed and its performance characteristics determined by the Power3 Medical Products Laboratories.BC-SeraPro™ is an ideal diagnostic test to evaluate breast cancer abnormalities

Power3 Medical Products (OTCBB: PWRM.OB) BC-SeraPro™ was developed and its performance characteristics determined by the Power3 Medical Products Laboratories.

Power3 Medical Products, Inc. (OTCBB:PWRM.OB) NuroPro was originally indicated for diagnostics to determine whether or not a patient had Alzheimer’s disease.

MRK reported that two pivotal Phase III registration studies for boceprevir, its investigational oral hepatitis C protease inhibitor.

Discovered new and unprecedented findings regarding clinically important

Its product candidates include BC-SeraPro, a blood serum protein breast cancer test for the diagnosis of breast cancer and to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer

With these results, PWRM’s NuroPro now extends into the pharmaceutical arena due to its ability to predict and monitor the response to drug treatment

discovered new and unprecedented findings regarding clinically important differences in the response of the NuroPro

PWRM.OB, ILMN, & VSYM.OB: ILMN has recently reported the production of the Eco Real-Time PCR System

PWRM is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.